Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

New research published in the American Journal of Health-System Pharmacy suggests a possible link between the GLP-1 drug ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about ...

As the burden of obesity grows globally, the interest in weight loss drugs has also risen proportionately. While the ...

Donald Trump recently made fun of his friend who takes Ozempic, adding that the weight-loss drug doesn’t seem to be working ...

Trump is benefiting from the medical infrastructure the government has built up, while simultaneously destroying that infrastructure for everyone else.

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

The best metric is not weight, but a particularly toxic kind of fat.

The U.S. Food and Drug Administration (FDA) has issued a warning to patients and healthcare professionals regarding the use ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...